Joon-Chul Kim1, Marta Pérez-Hernández1, Francisco J Alvarado2, Svetlana R Maurya3, Jerome Montnach4, Yandong Yin5, Mingliang Zhang1, Xianming Lin1, Carolina Vasquez1, Adriana Heguy6, Feng-Xia Liang7, Sun-Hee Woo8, Gregory E Morley6, Eli Rothenberg5, Alicia Lundby3,9, Hector H Valdivia2, Marina Cerrone1, Mario Delmar1. 1. The Leon H. Charney Division of Cardiology (J.C.K., M.P.H., M.Z., X.L., C.V., M.C., M.D.), New York University School of Medicine. 2. Department of Medicine and Cardiovascular Research Center, University of Wisconsin-Madison School of Medicine and Public Health (F.J.A., H.H.V.). 3. Department of Biomedical Sciences (S.R.M., A.L.), Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. 4. Institut du Thorax, Nouvelle Universite a Nantes, INSERM, Nantes Cedex 1, France (J.M.). 5. Department of Pharmacology and Biochemistry (Y.Y., E.R.), New York University School of Medicine. 6. Department of Pathology and Genome Technology Center (A.H., G.E.M.), New York University School of Medicine. 7. Microscopy Laboratory, Division of Advanced Research Technologies (F.X.L.), New York University School of Medicine. 8. Laboratory of Physiology, College of Pharmacy, Chungam National University, Daejeon, South Korea (S.H.W.). 9. NNF Center for Protein Research (A.L.), Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Abstract
BACKGROUND: Plakophilin-2 (PKP2) is classically defined as a desmosomal protein. Mutations in PKP2 associate with most cases of gene-positive arrhythmogenic right ventricular cardiomyopathy. A better understanding of PKP2 cardiac biology can help elucidate the mechanisms underlying arrhythmic and cardiomyopathic events consequent to PKP2 deficiency. Here, we sought to capture early molecular/cellular events that can act as nascent arrhythmic/cardiomyopathic substrates. METHODS: We used multiple imaging, biochemical and high-resolution mass spectrometry methods to study functional/structural properties of cells/tissues derived from cardiomyocyte-specific, tamoxifen-activated, PKP2 knockout mice (PKP2cKO) 14 days post-tamoxifen injection, a time point preceding overt electrical or structural phenotypes. Myocytes from right or left ventricular free wall were studied separately. RESULTS: Most properties of PKP2cKO left ventricular myocytes were not different from control; in contrast, PKP2cKO right ventricular (RV) myocytes showed increased amplitude and duration of Ca2+ transients, increased Ca2+ in the cytoplasm and sarcoplasmic reticulum, increased frequency of spontaneous Ca2+ release events (sparks) even at comparable sarcoplasmic reticulum load, and dynamic Ca2+ accumulation in mitochondria. We also observed early- and delayed-after transients in RV myocytes and heightened susceptibility to arrhythmias in Langendorff-perfused hearts. In addition, ryanodine receptor 2 in PKP2cKO-RV cells presented enhanced Ca2+ sensitivity and preferential phosphorylation in a domain known to modulate Ca2+ gating. RNAseq at 14 days post-tamoxifen showed no relevant difference in transcript abundance between RV and left ventricle, neither in control nor in PKP2cKO cells. Instead, we found an RV-predominant increase in membrane permeability that can permit Ca2+ entry into the cell. Connexin 43 ablation mitigated the membrane permeability increase, accumulation of cytoplasmic Ca2+, increased frequency of sparks and early stages of RV dysfunction. Connexin 43 hemichannel block with GAP19 normalized [Ca2+]i homeostasis. Similarly, protein kinase C inhibition normalized spark frequency at comparable sarcoplasmic reticulum load levels. CONCLUSIONS: Loss of PKP2 creates an RV-predominant arrhythmogenic substrate (Ca2+ dysregulation) that precedes the cardiomyopathy; this is, at least in part, mediated by a Connexin 43-dependent membrane conduit and repressed by protein kinase C inhibitors. Given that asymmetric Ca2+ dysregulation precedes the cardiomyopathic stage, we speculate that abnormal Ca2+ handling in RV myocytes can be a trigger for gross structural changes observed at a later stage.
BACKGROUND:Plakophilin-2 (PKP2) is classically defined as a desmosomal protein. Mutations in PKP2 associate with most cases of gene-positive arrhythmogenic right ventricular cardiomyopathy. A better understanding of PKP2 cardiac biology can help elucidate the mechanisms underlying arrhythmic and cardiomyopathic events consequent to PKP2 deficiency. Here, we sought to capture early molecular/cellular events that can act as nascent arrhythmic/cardiomyopathic substrates. METHODS: We used multiple imaging, biochemical and high-resolution mass spectrometry methods to study functional/structural properties of cells/tissues derived from cardiomyocyte-specific, tamoxifen-activated, PKP2 knockout mice (PKP2cKO) 14 days post-tamoxifen injection, a time point preceding overt electrical or structural phenotypes. Myocytes from right or left ventricular free wall were studied separately. RESULTS: Most properties of PKP2cKO left ventricular myocytes were not different from control; in contrast, PKP2cKO right ventricular (RV) myocytes showed increased amplitude and duration of Ca2+ transients, increased Ca2+ in the cytoplasm and sarcoplasmic reticulum, increased frequency of spontaneous Ca2+ release events (sparks) even at comparable sarcoplasmic reticulum load, and dynamic Ca2+ accumulation in mitochondria. We also observed early- and delayed-after transients in RV myocytes and heightened susceptibility to arrhythmias in Langendorff-perfused hearts. In addition, ryanodine receptor 2 in PKP2cKO-RV cells presented enhanced Ca2+ sensitivity and preferential phosphorylation in a domain known to modulate Ca2+ gating. RNAseq at 14 days post-tamoxifen showed no relevant difference in transcript abundance between RV and left ventricle, neither in control nor in PKP2cKO cells. Instead, we found an RV-predominant increase in membrane permeability that can permit Ca2+ entry into the cell. Connexin 43 ablation mitigated the membrane permeability increase, accumulation of cytoplasmic Ca2+, increased frequency of sparks and early stages of RV dysfunction. Connexin 43 hemichannel block with GAP19 normalized [Ca2+]i homeostasis. Similarly, protein kinase C inhibition normalized spark frequency at comparable sarcoplasmic reticulum load levels. CONCLUSIONS: Loss of PKP2 creates an RV-predominant arrhythmogenic substrate (Ca2+ dysregulation) that precedes the cardiomyopathy; this is, at least in part, mediated by a Connexin 43-dependent membrane conduit and repressed by protein kinase C inhibitors. Given that asymmetric Ca2+ dysregulation precedes the cardiomyopathic stage, we speculate that abnormal Ca2+ handling in RV myocytes can be a trigger for gross structural changes observed at a later stage.
Entities:
Keywords:
arrhythmogenic right ventricular cardiomyopathy; connexin43; plakophilin 2; right ventricle; sudden death
Authors: Stephan B Danik; Fangyu Liu; Jie Zhang; H Jacqueline Suk; Gregory E Morley; Glenn I Fishman; David E Gutstein Journal: Circ Res Date: 2004-10-21 Impact factor: 17.367
Authors: D E Gutstein; G E Morley; H Tamaddon; D Vaidya; M D Schneider; J Chen; K R Chien; H Stuhlmann; G I Fishman Journal: Circ Res Date: 2001-02-16 Impact factor: 17.367
Authors: Vandana Verma; Maurice B Hallett; Luc Leybaert; Patricia E Martin; W Howard Evans Journal: Eur J Cell Biol Date: 2008-10-31 Impact factor: 4.492
Authors: D Eckardt; M Theis; J Degen; T Ott; H V M van Rijen; S Kirchhoff; J-S Kim; J M T de Bakker; K Willecke Journal: J Mol Cell Cardiol Date: 2004-01 Impact factor: 5.000
Authors: Jorge E Contreras; Juan C Sáez; Feliksas F Bukauskas; Michael V L Bennett Journal: Proc Natl Acad Sci U S A Date: 2003-09-16 Impact factor: 11.205
Authors: Amanda E Bass-Zubek; Ryan P Hobbs; Evangeline V Amargo; Nicholas J Garcia; Sherry N Hsieh; Xinyu Chen; James K Wahl; Mitchell F Denning; Kathleen J Green Journal: J Cell Biol Date: 2008-05-12 Impact factor: 10.539
Authors: Maarten Aj De Smet; Alessio Lissoni; Timur Nezlobinsky; Nan Wang; Eef Dries; Marta Pérez-Hernández; Xianming Lin; Matthew Amoni; Tim Vervliet; Katja Witschas; Eli Rothenberg; Geert Bultynck; Rainer Schulz; Alexander V Panfilov; Mario Delmar; Karin R Sipido; Luc Leybaert Journal: J Clin Invest Date: 2021-04-01 Impact factor: 14.808
Authors: Marta Pérez-Hernández; Chantal J M van Opbergen; Navratan Bagwan; Christoffer Rasmus Vissing; Henning Bundgaard; Mario Delmar; Alicia Lundby; Grecia M Marrón-Liñares; Mingliang Zhang; Estefania Torres Vega; Andrea Sorrentino; Lylia Drici; Karolina Sulek; Ruxu Zhai; Finn B Hansen; Alex H Christensen; Søren Boesgaard; Finn Gustafsson; Kasper Rossing; Eric M Small; Michael J Davies; Eli Rothenberg; Priscila Y Sato; Marina Cerrone; Thomas Hartvig Lindkær Jensen; Klaus Qvortrup Journal: Circulation Date: 2022-08-12 Impact factor: 39.918
Authors: Chantal J M van Opbergen; Navratan Bagwan; Alicia Lundby; Mario Delmar; Svetlana R Maurya; Joon-Chul Kim; Abigail N Smith; Daniel J Blackwell; Jeffrey N Johnston; Björn C Knollmann; Marina Cerrone Journal: Circulation Date: 2022-05-01 Impact factor: 39.918
Authors: Chantal J M van Opbergen; Joseph Sall; Chris Petzold; Kristen Dancel-Manning; Mario Delmar; Feng-Xia Liang Journal: Front Cell Dev Biol Date: 2022-03-08
Authors: Marta Pérez-Hernández; Alejandra Leo-Macias; Sarah Keegan; Mariam Jouni; Joon-Chul Kim; Esperanza Agullo-Pascual; Sarah Vermij; Mingliang Zhang; Feng-Xia Liang; Paul Burridge; David Fenyo; Eli Rothenberg; Mario Delmar Journal: Circ Res Date: 2020-12-21 Impact factor: 17.367